Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulation of HO-1 by Nizatidine and Lisinopril in Healthy Subjects
NCT02232308Phase 1Completed
- Start
- Jul 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nizatidine and lisinopril in gastroparesis (4 arms). Primary endpoints: Change in plasma heme oxygenase 1 (HO-1) protein concentration at Day 10 and Change in Monocyte HO-1 activity at Day 10. Started Jul 2014; status: completed.
02
Drugs
nizatidinelisinopril
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT02232308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232308.